Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Novel Glaucoma Diagnostics

Wills Eye · with National Eye Institute (NEI) · NCT00286637

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
5000
US sites recruiting
1
Study start
August 1, 2000
Record last updated
August 15, 2024

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this research is to evaluate novel technologies for the assessment of ocular structure and function, including the scanning device called Optical Coherence Tomography (OCT). We will test the OCT and other devices in their ability to image diseases of the eye and also compare the measurements made with OCT to those of other imaging and visual field devices approved by the Food and Drug Administration (FDA). OCT may be useful for the early diagnosis and monitoring of a variety of types of eye diseases

Conditions: Glaucoma; Macular Disease

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Ability to provide informed consent and to understand the study procedures
  • Healthy volunteers
  • Age related macular degeneration (AMD), diabetic retinopathy, central serous chorioretinopathy, and/or glaucoma or glaucoma suspects
  • (AD Sub-Study ONLY): Subjects diagnosed with AD or MCI.

Exclusion Criteria

  • Any medical treatment (e.g., chronic corticosteroid, hydroxychloroquine, chloroquine, thioridazine, canthaxanthine) or conditions that affect VF (e.g., stroke) and retinal thickness other than glaucoma.
  • Strabismus, nystagmus, or any condition that prevents fixation.
  • Presence of any media opacities that hinders clinical view of the fundus, and any intraocular non-glaucomatous abnormality
  • History of ocular trauma or intraocular surgery other than uncomplicated glaucoma interventions or cataract extraction at least 3 months previous to participating in the study.

Recruiting US locations

  • Wills Eye Hospital

    Philadelphia, PA 19107

    Site contact: Taylor Harwood · 215-928-3197 · tharwood@willseye.org

Study contacts (from the official record)

  • Taylor Harwood · 215-928-3197 · tharwood@willseye.org
  • Ronald Zambrano · 215-928-3197 · rzambrano@willseye.org
All diabetes studies in Pennsylvania →
Novel Glaucoma Diagnostics (NCT00286637) | Bored Studies